(Total Views: 111)
Posted On: 04/12/2022 11:15:57 AM
Post# of 107318

$VTGN News Article - VistaGen and AffaMed Complete Key Regulatory Submissions for PALISADE Global Phase 3 Clinical Trial for PH94B https://marketwirenews.com/news-releases/vist...90286.html


My Twitter: WhyteStocks